ArticleCureus2025

Delayed Recovery of a Disintegrin-Like and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) Activity in Immune Thrombotic Thrombocytopenic Purpura Treated With Caplacizumab and Rituximab.

Yusuke Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.